Pasithea Therapeutics Corp (KTTA) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Pasithea Therapeutics (KTTA) kompaniyasida neyropreparatlarning ishlab chiqilishi, sintez va sinovlar xorijiy cGMP markazlariga taqsimlangan holda virtual modellashtirishga asoslangan, klinik sinovlarning yuqori xarajatlari va FDA ning qat'iy nazorati esa raqobatchilar uchun kirishga jiddiy to'siq yaratadi. Ushbu narxlar grafigi aktivning dinamikasini aks ettiradi va uning qiymati 0.00 ni tashkil etadi. Hozirgi vaqtda Pasithea Therapeutics (KTTA) antidepressantlar bo'yicha tadqiqotlarni moliyalashtirish uchun o'zining mavjud likvidligidan tizimli ravishda foydalanmoqda.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_KTTA_-_Pasithea-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "KTTA - Pasithea Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Pasithea Therapeutics kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Pasithea Therapeutics|KTTA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati Pasithea|KTTA - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Pasithea Therapeutics Corp.|KTTA - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Pasithea Therapeutics|Oraliq qoplama koeffitsiyenti pasitheaclinics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:KTTA, pasitheaclinics.com
Neyroterapiya tahlili uchun dasturiy robotlarning joriy etilishi kapital xarajatlarni talab qiladi, bu esa Pasithea Therapeutics (KTTA) kompaniyasining joriy uzoq muddatli qarzdorlikning kapitalga nisbati ko'rsatkichida aks etgan. Ushbu metrika bir yildan ortiq muddatga ega majburiyatlarni aksiyadorlar kapitali bilan solishtiradi. Ko'rsatkich uzoq muddatli kreditlarni kapital qiymatiga bo'lish orqali hisoblanadi. Ushbu indikatorning keskin pasayishi kreditlarning qaytarilishi emas, balki aksiyalar narxining oshishidan dalolat berishi mumkin. Bu Pasithea Therapeutics moliyaviy barqarorligini baholash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|harmonybiosciences.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BHVN|Uzoq muddatli qarzning kapitalga nisbati Amylyx Pharmaceuticals Inc (AMLX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Uzoq muddatli qarzdorlikning kapitalga nisbati Praxis Corp (PRAX)|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ceribell.com CBLL|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALEC: Uzoq muddatli kreditlarning kapitalga nisbati|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|OMER: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati NGNE|ACIU - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Neumora NMRA|SCLX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG (alphacognition.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CGTX: Uzoq muddatli kreditlarning kapitalga nisbati|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|SAVA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ASRT|COYA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Vistagen VTGN|Uzoq muddatli qarzning kapitalga koeffitsiyenti OVID|Acumen Pharmaceuticals, Inc. - Uzoq muddatli qarzning kapitalga nisbati|CRVO - Uzoq muddatli qarzning kapitalga nisbati|alteritytherapeutics.com (ATHE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati CLNN (Clene)|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati jupiterneurosciences.com JUNS|Uzoq muddatli qarzning o'z kapitaliga nisbati RLMD (Relmada Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Annovis Bio Inc (ANVS)|Grace Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati AIFF (Firefly Neuro)|ANEW Medical, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati NeuroSense Therapeutics NRSN|RVPH: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati MetaVia|Uzoq muddatli qarzning o'z kapitaliga nisbati NeurAxis, Inc|Helius Medical Technologies Inc. (HSDT) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio, Inc. (PASG)|Uzoq muddatli qarzning kapitalga nisbati bionomics.com.au (NEUP)|Minerva Neurosciences, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati ATHA (Athira Pharma Inc)|ADXN: Uzoq muddatli qarzning o'z kapitaliga nisbati|Alzamend Neuro, Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|CYCN: Uzoq muddatli qarzning kapitalga nisbati|Protagenic Therapeutics, Inc. (PTIX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning kapitalga nisbati BCLI|CARA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Chromocell Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Eliem Therapeutics, Inc. ELYM|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti LBPH (Longboard Pharmaceuticals Inc)|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp (NKGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|sagerx.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning kapitalga nisbati Trevena Inc. (TRVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Uzoq muddatli qarzdorlikning kapitalga nisbati Anew Medical Inc. (WENA)|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati